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Justicia pectoralis Jacq., Acanthaceae, is a herb known popularly in Cuba as Tilo and used traditionally 
as sedative. The development in a solid pharmaceutical (Tablets 100 mg) using dry extract of Justicia 
pectolaris aqueous extract is of interest for the development of phytomedicines, which uses this active 
raw material. The aim of the present study was to carry out chemical and biological stability studies to 
the formulation. A method of coumarin determination by High Performance Liquid Chromatography 
(HPLC) was used and validated. The stability studies during different periods of time (24 months) showed 
a stability of the product stored at 32 ± 2 °C, and protected of the light.
Uniterms: Justicia pectoralis/pharmacognosy. Medicinal plants. Phytomedicines. Coumarins/
determination. High Performance Liquid Chromatography/phytomedicines analysis. Phytomedicines/
stability studies. Tilo®/tablets/stability studies.
Justicia pectoralis Jacq., Acanthaceae é uma erva conhecida popularmente em Cuba como Tilo e utilizada 
tradicionalmente como sedativo. O desenvolvimento de formas farmacêuticas sólidas (comprimido 
100 mg) usando extrato aquoso seco de J. pectoralis é de interesse no desenvolvimento de fitoterápicos 
que empreguem esse princípio ativo. O objetivo do presente estudo foi realizar estudos de estabilidade 
químicos e biológicos da formulação. Um método de determinação de cumarinas por Cromatografia 
Líquida de Alta Eficiência (CLAE) foi usado e devidamente validado. Os estudos de estabilidade durante 
diferentes períodos de tempo (24 meses) mostraram a estabilidade do produto preservado a 32 ± 2 °C 
e protegido da luz.
Unitermos: Justicia pectoralis/farmacognosia. Plantas medicinais. Fitoterápicos. Cumarinas/
determinação. Cromatografia Líquida de Alta Eficiência/análise de fitoterápicos. Fitoterápicos/estudos 
de estabilidade. Tilo®/estudos de estabilidade.
INTRODUCTION
The development of natural products pharmaceuticals 
is one of the main lines of research and development of the 
Cuban pharmaceutical industry. Justicia pectoralis Jacq is a 
medicinal plant studied for its sedative property. This plant 
is a herbaceous of the Acanthaceae family species, known in 
Cuba as Tilo, and used as a traditional sedative by the Cuban 
population. (Rivero, Rodríguez, 2000; La Serna et al., 1989).
Justicia pectoralis Jacq dry extract was obtained 
from hydroalcoholic and aqueous extracts by spray 
dried technology. Coumarin is one of the main active 
phytochemicals of the dry extract, and could be used as 
analytic marker (Rodríguez et al., 2008a; Rodríguez et al., 
2013; Rodríguez, Rodríguez, 2014). Justicia pectoralis 
Jacq dry extract has been used as active principle in 
a liquid formulation stable chemical, physical, and 
technologically for 36 months (Paz et al., 2011).
Tablets containing 100 mg of Justicia pectoralis 
Jacq dry extract were prepared. A method of coumarin 
determination by HPLC was developed and validated. 
The aim of the present study was to carry out chemical and 
biological stability studies to the formulation.
MATERIAL AND METHODS
On the basis of previous results (not published), 
three batches (04001, 04002 and 04003) of 5 kg of 
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total mass to pilot scale (about 15 600 tablets) each one 
were prepared according to the technological process 
developed in the Drug Investigation and Developed 
Center (CIDEM, acronym for Centro de Desarrollo e 
Investigación de Medicamentos). The active principle 
was Tilo® dry extract, obtained according to technological 
process developed by Rodriguez et al, 2013a. Tablets were 
prepared by wet granulation method, containing 100 mg 
of Tilo® dry extract; and common exicipients as maize 
starch (Roquette, Italy, polyvinylpyrrolidone (Kollidon 
K25®) (Basf, Alemania), lactose (Xinan, China), sodium 
starch glicolate (Blanver, Brasil), talc (Olimpic, Mexico), 
and magnesium estearate (Xinan, China) in appropriate 
proportions were used in the preparation.
A wet massing (Planetary granulation equipment 
model HOBART, Germany) process followed by a drying 
of Tilo® granules (Fluidized-bed dryer equipment model 
VIANI, Italy) process was used to prepare the tablets. Each 
tablet of 320 ± 10 mg containing 100 mg Tilo® dry extract 
was compressed on a rotary tablet machine (MANESTY 
F3, Italy) using flat-faced, beveled punches of 8 mm 
diameter, at a speed of 110 tablet/min. The hardness of the 
tablets was fixed at 9 ± 1 kgf/Monsanto, and the height at 
4.5 mm ± 5%. Each batch was packaged in high-density 
polyethylene plastic container.
Analysis assay
A coumarin determination method by Liquid 
Chromatography of High Resolution (HPLC) with UV 
detection technique was developed. Separation was 
achieved (HPLC KNAUER, Germany) on reverse phase 
L1 (C18) (5 μm, 250 mm × 4 mm, Merck, Germany) 
column (Lichrospher® 100, Merck, Germany). All 
chromatographic runs were performed using methanol - 
water in the ratio of 40:60 v/v as the mobile phase. The 
parameters employed were: flow rate was 1 mL/min, UV 
detection at 274 nm, and at injection volume 20 µL.
Sample preparation
About 60 mg of active pharmaceutical ingredient 
was weighed, and later on dissolved and diluted in 100 mL 
of mobile phase.
Standards preparation
 To prepare a standard solution containing coumarin 
(Aldrich Chemical Co.) and 7 hydroxycoumarin (Aldrich 
Chemical Co.) 25 mg, accurately weighed amounts of each 
compound were dissolved in 100 mL of mobile phase. 
Two mililiters of this solution were dissolved in 50 mL 
of mobile phase to give amounts of 10 μg, respectively.
Validation of analytical method
Specificity and selectivity of the method was 
evaluated. Samples of raw material, placebo (tablets 
without active principle) and Tilo® tablets were placed 
under the following relevant stress conditions: heat (70 °C 
during 72 hours), acid/base hydrolysis (HCl 1 mol/L, 
70 °C during 72 hours or NaOH 1 mol/L, 70 °C during 
72 hours), and oxidation (30% H2O2 solution during 24 
hours). Once the experimint ended, the chromatograms 
of each assay were carried out (ICH, 2005).
The precision (repeatability and intermediate 
precision) was established by assaying 10 different 
samples of the same lot, by two different analysts in 
different days, with the proposed chromatographic 
method. Mean, standard deviation (DS) and coefficient 
of variation (CV) for each analyst were determined. The 
statistic differences were tested by means of the Student 
test and Fisher test (ICH, 2005).
To evaluate the accuracy, the analyses of samples 
with known amounts of coumarin standard (equivalent 
to concentrations between the 60 and 130% of the 
concentration of present coumarin in the lot in study), 
were carried out. In each point, the variation coefficient 
and recovery percentages were determined. The statistic 
differences between recovery mean and 100% of recovery 
was tested by the Student test. The G of Cochran was 
determined to know if the concentrations variances were 
equivalent (ICH, 2005).
Linearity was evaluated by means of a calibration 
curve of the signals as a function of analyte concentration. 
A curve with 0,65, 0,98, 1,09, 1,20, and 1,42 mg of 
coumarin concentration (equivalent to concentrations 
between the 60 and 130% of the concentration of present 
coumarin in the lot in study) was prepared. Each sample 
was analysed, and the peak areas were recorded. The 
intercepts significance was determined by the Student test, 
and the linearity test was applied (ICH, 2005).
The range was evaluated between 90 and 110% of 
the coumarin concentration contained in the test lot. The 
prepared samples for the determination of the accuracy 
were used, and a suitable level of precision, accuracy, and 
linearity of the analytical procedure was demonstrated 
(ICH, 2005).
In vitro dissolution
In vitro dissolution of the tablets was determined 
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according to Rodríguez and Gil, 2013. A PHARMA TEST, 
model PTW S3C (Germany) dissolutor was used. The in 
vitro dissolution test was carried out using type II (paddle) 
dissolution apparatus with 500mL of distilled water at 
37 ± 0,5 °C and 100 rpm. Coumarin content was determined 
in aliquots by the analytical procedure previously described.
Stability study
The studied lots were placed at 40 ± 2 °C/75 ± 5% 
relative humidity (RH) for 6 months (accelerated study), 
and 30±2 °C/70 ± 5% RH for 24 months (long-term study). 
In the accelerated study the samples were evaluated to 
0, 1, 2, 3 and 6 months, while in the long-term study the 
samples were evaluated to 0, 6. 12, 18 and 24 months. In 
both studies the coumarin content and in vitro dissolution 
were determined (ICH, 2003).
In the photostability test, the 90 days´samples were 
exposed to light source (ICH, 1996). In the humidity 
study, the 180 days´ samples in plastic container (open and 
closed) at 84, 92 and 98 % of relative humidity ere exposed 
(ICH, 2003). Once both conclulded, both experiments the 
coumarin content and in vitro dissolution were determined.
Pharmacological studies
To know if the sedative activity was affected in the 
time, the pharmacological evaluation was carried out to 
0, 12, and 24 months.
Animals
Male albino mice (Swiss, 18-22g) in thiopental-
induced sleep, open field activity and aggressive 
behaviours test.
All animals were housed in groups of five under 
standard laboratory conditions of temperature, humidity 
and lighting (12:12-h light/dark). Animals had free access 
to food and water, except during experiment. They were 
deprived of food, but not of water, 6h before the drug 
administration, and each group consisted of ten animals. 
All experiments were carried out between 8:00 am to 
11:00 am in accordance with the Institutional Animal 
Ethical Committee approved the study, and animal care 
was in conformity with Canadian Council for Animal Care 
guidelines.
Pharmacological evaluation
In tablets samples, animals were divided into five 
groups: distilled water- treated group (NC), Diazepam 
(1 mg/kg) - treated group (PC) and Tilo® tablets (5, 20 and 
80 mg/kg) - treated groups.
Open field activity
The Open field activity was carried out according 
to a previously reported method with some modifications 
(Archer, 1977; Walsh, Cummins, 1976; Pinna et al., 2008). 
Thirty minutes after the administration of vehicle or test 
compound, a mouse was placed in the centre of a round 
open field of 30 cm diameter and 25 cm high, and the open 
field activity were measured during 6 minutes recording 
how many times the animal stays in the centre of the cage 
and the number of risings.
Aggressive behaviours
This study was realized according to the method 
described by Pinna et al. (2008). A group of animals was 
isolated in individual cage and other group remained 
grouped during six week. Thirty minutes after the 
administration of vehicle or test compound, the aggressive 
behaviours were evaluated through an intruder mouse 
into the isolated mice’s home cage, and were recorded 
the aggressive activity (biting attacks and wrestling) in 
isolated mice was measure as total fighting time during a 
20 min period.
Thiopental-induced sleep
The Thiopental-induced sleep study was realized 
according to the method described by Fernandez et 
al., 2005. Thiopental Sodium (50 mg/kg) was injected 
intraperitoneally 30 min after administration of distilled 
water or test compound. An animal was placed on its back 
on a warmed (35 °C) pad. The number of sleeping animals 
and the duration of loss of righting reflex were recorded. 
The duration from loss of righting reflex until a mouse 
regained its righting reflex was measured.
Statistical analysis
Experimental results are expressed as Means ± SD, 
and were assessed by an analysis of variance (ANOVA) 
and later were carried out a test of Duncan. Results were 
considered significant when p <0.05.
The results obtained in the different experiments 
were statistically processed using STATGRAPHICS 
PLUS version 5.1 (Statistical Graphics Corp., USA) 
software, and the statistical charts of the Fisher tests and 
Student test.
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RESULTS AND DISCUSSION
Flat-faced, beveled and grooved tablets, of marbled 
brown colour, with characteristic odour to the plant, 
were obtained. The coumarin content of all the tablets 
batches were between 1,05 and 1,15 mg/tab (Acceptable 
limits not less than 0.70 mg/tab). The results of the in 
vitro dissolution assays were between 92,0 and 101,0% 
(Not less than 80% of the coumarin content quantified in 
the sample in 60 minutes is an acceptable limit for this 
assay). These results showed that all the lots respond to 
the established specifications of quality. The viability of 
the developed process was demonstrated.
Validation of analytical method
The chromatogram of standard mixture is shown 
in Figure 1. The retention time of coumarin and 
7-hydroxycoumarin were 14,0 and 11,0 min, respectively. 
This result demonstrates that both components can be 
effectively separated by HPLC methods developed.
Specificity is the ability to assess unequivocally 
the analyte in the presence of components, which may be 
expected to be present. These might include impurities, 
degradants, and matrix, among others (ICH, 2005). The 
chromatograms of raw material, Tilo® tablets and placebo 
are shown in Figure 2. Coumarin can be determined in 
raw material and Tilo® tablets, by means of the developed 
method. One inspection of chromatograms of these 
samples (Figure 2a and 2b) showed the retention time 
of coumarin at 14,0 min, similar to standard reference. 
There was not peak found at their retention time in the 
placebo sample (Figure 2c). This result confirms that the 
other components of the formulation do not interfere in 
the coumarin determination. 
In NaOH 1 mol/L and 70 °C during 72 hours, 
a decrease was observed in the intensity of the peak 
corresponding to coumarin (retention time=14 min) in the 
chromatograms of the tablets. Peaks degradation was not 
observed (Figure 2d). Meanwhile, in 30% H2O2 solution 
during 24 hours, a significant decrease of coumarin peak 
and the appearance of a degradation peak corresponding 
to 7-hydroxycoumarin (retention time = 11 min) in the 
chromatograms of tablets were observed. Similar results 
were observed in the raw material samples.
The vast majority of the coumarins are oxygenated 
at C-7, 7-hydroxycoumarin is frequently considered 
to be the parent compound for the more structurally 
complex members of the family (Keating, O’Kennedy, 
1997). Similar results were reported by Rodriguez et al. 
(2008b). In the rest of the treatments studied, changes in 
the chromatograms were not observed. The results of this 
study demonstrated that the method described is capable 
of simultaneously quantitating both components in Tilo® 
tablets.
The results of the precision study (analyst 1: 1,13 
± 0,023 (mean ± DS) and 1,92% (CV); analyst 2: 1,12 
± 0,014 (mean ± DS) and 1,27% (CV)) showed values 
of coefficients of variation smaller than the established 
limits for chromatographic methods (< 2%) (ICH, 
FIGURE 1 - Chromatogram of standard mixture (14,0 min: coumarin and 11,0 min: 7-hydroxycoumarin).
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2005). The experimental value of Fisher test (Fexperimental 
= 2,319) was smaller than the theoretical Fisher test 
value (Ftheoretical = 3.18 from F9/9), and the experimental 
Student test value (texperimental = 0,432) was smaller than the 
theoretical Student test value (ttheoretical = 2.10 from df = 18).
The most important part of any analytical method 
validation is precision analysis. This is usually expressed 
as the variance, standard deviation, or variation coefficient, 
of a series of measurements (ICH, 2005). In this study, the 
results showed that the values of the variations coefficient 
agreed with the established limits for chromatographic 
methods, as well as the established criteria for the Fisher 
tests and Student test.
In the accuracy study, an equation of Y = 1.00X – 0.005 
with a correlation coefficient of 0.998 for n = 15, was 
obtained in the recovery curve. The variations of the 
coefficient values (0,78; 1,18; 1,39; 1,27 and 0,35% for 
theoretical concentration of coumarin of 0,65; 0,98; 1,09; 
1,20 and 1,42 mg, respectively) were smaller than the 
established limits for chromatographic methods (< 2%). 
The recovery percentages (99,2; 99,7; 100,6; 100,6 and 
99,6% for theoretical concentration of coumarin of 0,65; 
0,98; 1,09; 1,20 and 1,42 mg, respectively) were higher 
than 99%, and were among the 98 and 102%, acceptable 
limits in this analysis type (ICH, 2005). Comparative 
analyses with the mean recovery, and the 100% of the 
recovery by Student test, show that the experimental 
value (texperimental = 1,28) was smaller than the theoretical 
value (ttheoretical = 2.13 from df = 15). Meanwhile, the 
test of the G of Cochran showed an experimental value 
(Gexperimental = 0.308) smaller than the theoretical G 
(Gtheoretical = 0.684 for p = 0.05, K = 5 and n = 3). These 
results indicated an acceptable accuracy of the analytical 
method.
A regression equation of the calibrating curve: 
y=184547x - 93458, r=0,997 and r2= 0,994 (criteria of 
acceptance r=0,99 and r2=0,98) was obtained. When 
applying the test of Student, the experimental value 
(texperimental =1,94, p=0,263) for the intercept was obtained, 
while the proportionality test showed that the intercept 
was not significant (texperimental=26,1, p=0,007) according 
to the accepted criteria texperimental < ttheoretical (2,16 for n=15 
and p=0,05 for intercept and t=high, p << 0,005 for 
the proportionality). On the other hand, the variation 
FIGURE 2 - Results of specificity study (a: chromatogram of raw material sample; b: chromatogram of Tilo® tablets sample; 
c: chromatogram of placebo sample; d: chromatogram of Tilo® tablets sample in NaOH 1 mol/L, 70 °C during 72 hours and e: 
chromatogram of Tilo® tablets sample at 30% H2O2 solution during 24 hours).
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coefficient of the response factors (CVf) was of 2,94%, 
which is smaller than the established limit of 5% (ICH, 
2005).
In the range study, an equation of Y=1.05X - 0.05 
with a correlation coefficient of 0.992 for n=9, was obtained 
in the recovery curve. The variations of coefficient values 
(1,18; 1,39; and 1,27% for theoretical concentration of 
coumarin of 0,98; 1,09 and 1,20 mg, respectively) were 
smaller than the established limits for chromatographic 
methods (<2%), and the recovery percentages (99,7; 100,6 
and 100,6% for theoretical concentration of coumarin 
of 0,98; 1,09 and 1,20 mg, respectively) were higher 
to 99% and were among the 98 and 102%, acceptable 
limits in this analysis type (Rodríguez et al., 2008b). 
When being compared, the mean recovery and the 100% 
of the recovery by Student test, the experimental value 
(texperimental=2,08) was smaller than the theoretical value 
(ttheoretical=2.26 from df=9). Meanwhile, the test of the G of 
Cochran showed an experimental value (Gexperimental=0.333) 
smaller than the theoretical G (Gtheoretical=0.879 for p=0.05, 
K=3 and n=3). These results indicated an acceptable range 
of the analytical method.
Similar results were obtained in the studies of 
accuracy and range. The average percentage recovery 
was between the limit established for these assays. In both 
cases, the value of the variations coefficient agreed with 
the established limits for chromatographic methods.
The linearity of an analytical procedure is the 
ability to obtain test results directly proportional to 
the concentration of analyte in the sample within 
a given range. The most common method used for 
demonstrating linearity is least squares regression. In 
this study, a regression equation of the calibrating curve 
that responds to the established acceptance criteria was 
obtained.
Summaryzing, the method described is rapid, lineal, 
accurate, reproducible, and capable of simultaneously 
quantitating coumarin and 7-hydroxycoumarin in 
Tilo® tablets. It can thus be used for the routine 
analysis of sample stability and the quality control of 
Tilo® tablets.
Stability study
Knowledge about the chemical and physical stability 
of a product is extremely important in drug development, 
because it will dictate the shelf life of the marketed 
product (ICH, 1996; ICH, 2003; Zhou et al., 2009; 
Waterman, Adami, 2005). The most common reactions 
observed in pharmaceuticals are hydrolysis, dehydration, 
isomerization, oxidation, photodegradation, and specific 
interactions with formulation components (excipients and 
their impurities) (Narang et al., 2009).
The results of accelerated stability study showed 
after 6 months that the formulations satisfied the quality 
specifications in the container studied (Table I). A 
percentage of released drug higher than 90% (Not less 
than 80% of the coumarin content quantified in the sample. 
in 60 minutes is an acceptable limit for this assay) and 
coumarin content superiors to 1,0 mg/tab (Not less than 
0.70 mg/tab is an acceptable limit for this assay) during 
6 months were obtained. These results demonstrate that 
the temperature does not affect the quality of the product 
under the conditions of this investigation.
Coumarin concentration suffers a slight increase 
after 90 days in photostability study (Table II). It is 
known that the ultraviolet light excites the coumarins, 
transforming the cis-form in the trans-isomer. Apparently, 
in the trans-isomer the hydrogen atom of the phenol group 
forms a chelate with the unsaturated carbon atom, giving 
TABLE I - Analytic results of the lots under accelerated stability conditions
Dissolution (%)
Lots Initial 1 months 2 months 3 months 6 months
04001 97,9 / 1,47 97,7 / 0,85 96,8 / 1,65 96,4 / 0,99 96,6 / 0,54
04002 98,7 / 1,14 98,9 / 1,77 98,6 / 1,18 98,5 / 1,82 97,9 / 1,95
04003 99,6 / 1,21 99,1 / 0,71 99,4 / 1,44 98,8 / 1,90 98,9 / 0,79
Drug content (mg/tab)
Lots Initial 1 months 2 months 3 months 6 months
04001 1,10 / 0,06 1,10 / 0,09 1,09 / 0,07 1,09 / 0,06 1,08 / 0,05
04002 1,10 / 0,08 1,08 / 0,08 1,09 / 0,08 1,08 / 0,08 1,07 / 0,08
04003 1,07 / 0,07 1,07 / 0,08 1,08 / 0,08 1,07 / 0,08 1,06 / 0,08
The results correspond to mean / DS the average of three determinations (n=3)
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TABLE II - Results of the study of photostability
Lots
Dissolution (%) Drug content (mg/tab)
Initial 90 days Initial 90 days
04001 97,9 / 1,47 98,5 / 1,17 1,10 / 0,06 1,12 / 0,05
04002 98,7 / 1,14 98,9 / 1,02 1,10 / 0,08 1,13 / 0,02
04003 99,6 / 1,21 99,7 / 1,08 1,07 / 0,07 1,10 / 0,09
The results correspond to mean / DS the average of three determinations (n=3)
rise to a six-membered ring, which is the fluorophore. 
These with UV light, increase the fluorescence intensity 
(Tan et al, 1976). In our opinion, this phenomenon can 
explain the results obtained in the photostability studies, 
where the isomeric is not separated by the analysis 
method with an increment of the peak intensity in the 
chromatogram to the wavelength used (Tan et al., 1976; 
Keating, O’Kennedy, 1997).
In the humidity study in open plastic container, a 
decrease of the coumarin content of 15,6, 19,9 and 26,6% 
for the 84, 92 and 98% of relative humidity observed from 
the initial value (Figure 3). A maximum of saturation of 
water absorption was reached to the 120 days under our 
conditions (2,65; 3,21 and 3,53% for the 84, 92 and 98% 
of relative humidity, respectively), being proportional 
to the humidity conditions. In vitro dissolution studies, 
a coumarin concentration decrease with the increment 
of the concentration of relative humidity and a total 
disintegration of the tablets in the means, was observed 
(Figure 3). Significant changes in the organoleptic 
characteristic (doughy consistency and darker colour) and 
a retention time peak at 11 minutes, in the chromatogram, 
characteristic of the 7-hydroxycoumarin were detected 
(Rodríguez, Rodríguez, 2014).
In the humidity study in closed plastic container, 
an extreme behaviour as the previously described was 
not observed. Although, it also exists a decrease of the 
coumarin content of 3,4, 4,3 and 5,2% for the 84, 92 
and 98% of relative humidity respectively, from the 
initial value (Figure 3). A maximum of saturation of 
water absorption was reached at the 180 days under our 
conditions (0,10; 0,10 and 0,12% for the 84, 92 and 98% 
of relative humidity, respectively). Contrary to the study 
with open plastic container, significant changes in the 
coumarin concentration and in vitro dissolution were 
not observed.
The coumarins are oxidized in presence of water, 
forming different oxygenated compounds. The most 
common is the umbelliferona (7-hydroxycoumarin), 
considered the compound structurally more complex of 
this family, and the biggest metabolite in the coumarin. The 
chemical is considered the main product of degradation 
of the simple coumarin (Keating, O’Kennedy, 1997). 
The results of the study of humidity confirmed that the 
active principle is affected with the formation of the 
7-hydroxycoumarin.
Our studies demonstrated that the main factors 
that affect the tablets stability were the light and the 
relative humidity of the environment. Similar results were 
observed in studies with the raw material (Rodríguez et 
al, 2008a; Rodríguez et al, 2013). These aspects must be 
controlled during the elaboration and storage of the tablet 
formulations.
According to the long-term study, it was verified that 
the formulation showed high chemical stability during 24 
months in the container studied (Table III).
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FIGURE 3 - Analytic results up to 180 days under different 
humidity conditions (a) Coumarin content and (b) % of 
saturation).
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Pharmacological studies
Reduced spontaneous locomotors activity in mice 
and rearing in a dose-dependent manner were observed in 
the open field activity study (Figures 4a and 4b). Usually, 
the rodents show an exploratory behaviour when they are 
collocated in a novel place. However, if the animals are 
pre-treated with depressant drugs, the locomotors activity 
decreases. Doses of 80 mg/kg of test compound showed 
similarity behaviour to diazepam 1 mg/kg (standard 
anxiolytic drugs). This result is typical of sedative drugs. 
Figure 4 (c and d) shows the effects of test compound 
on aggressive behaviour in isolated mice, test compound 
reduces an aggressive behaviour in a dose-dependent 
manner. A similar result to open field test between 
80 mg/kg of dried powder and diazepam 1 mg/kg doses 
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FIGURE 4 - Pharmacological evaluation in the time. (a) Results of open field activity in mice treated with Tilo® tablets; (b) Results 
of aggressive study in mice treated with Tilo® tablets; (c) Effect of Tilo® tablets on Thiopental induced sleep in mice. Time of 
appearance of dream induced and (d) Effect of Tilo® tablets on Thiopental induced sleep in mice. Time of duration of dream). 
Similar letter no significant for p < 0.05.
TABLE III - Analytic results of the lots under long-term stability conditions
Dissolution (%)
Lots Initial 6 months 12 months 18 months 24 months
04001 97,9 / 1,47 97,1 / 2,74 99,7 / 3,11 99,2 / 1,94 99,3 / 3,75
04002 98,7 / 1,14 98,4 / 2,84 98,7 / 1,50 98,4 / 1,04 98,3 / 1,75
04003 99,6 / 1,21 99,6 / 1,04 99,5 / 2,29 99,2 / 1,85 99,1 / 2,83
Drug content (mg/tab)
Lots Initial 6 months 12 months 18 months 24 months
04001 1,10 / 0,06 1,03 / 0,05 1,01 / 0,09 0,99 / 0,05 1,01 / 0,06
04002 1,10 / 0,08 1,04 / 0,01 1,00 / 0,07 0,99 / 0,02 0,99 / 0,04
04003 1,07 / 0,07 1,04 / 0,05 0,98 / 0,05 1,02 / 0,01 0,99 / 0,05
The results correspond to mean / DS the average of three determinations (n=3)
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was obtained. This behaviour was reported by Valzelli 
(1973) as a sign classic of central nervous system 
depressor.
The time of appearance of dream induced in animals 
treated with the different doses of Tilo ® tablets was 
significantly smaller (p <0,05) than the obtained with the 
animals of the group negative control. All test compound 
doses increased the number of sleeping animals compared 
with the control, doses of 20 and 80 mg/kg caused sleep 
in all animals. The behaviour to doses of 80 mg/kg and 
diazepam 1 mg/kg was similar in all animals.
Similar results were obtained in the studies to the 12 
and 24 months in each assay.
Our results show an anti-aggressive behaviour 
in tablets-treated mice this result can be mediated by 
inhibitory effects on brain biogenic amines action, or 
excitatory neurotransmitter release and suggest the 
inhibitory effect on the central nervous system; this 
suggestion was strengthened by the increase in sleeping 
time in the test-compound treated groups in the control 
group in the model of thiopental-induced sleep. Similar 
results were observed during raw material studies 
and confirm the sedative effect of the Tilo® tablets 
(Rodríguez et al., 2013). The pharmacological stability 
study demonstrated that the product maintains its 
pharmacological activity for 24 months.
CONCLUSIONS
The results evidenced the linearity, precision, 
specificity, accuracy, and range of the developed 
method for the coumarin quantification in Tilo® tablets. 
The selected formulation showed good chemical and 
pharmacological stability, with optimum in vitro drug 
release during 24 months in the studied container, stored 
at 32 ± 2 °C, and protected from the humidity and light.
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